Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
92.5M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
21.5M
-
Shares change
-
-2.59M
-
Total reported value, excl. options
-
$84.7M
-
Value change
-
-$10.2M
-
Put/Call ratio
-
4.1
-
Number of buys
-
19
-
Number of sells
-
-27
-
Price
-
$3.94
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q1 2023
66 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share as of Q1 2023.
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.5M shares
of 92.5M outstanding shares and own 23.25% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.26M shares), GOLDMAN SACHS GROUP INC (2.55M shares), VR Adviser, LLC (2.21M shares), BlackRock Inc. (2.07M shares), MILLENNIUM MANAGEMENT LLC (1.73M shares), Bleichroeder LP (1.33M shares), Point72 Asset Management, L.P. (1.28M shares), Alta Fundamental Advisers LLC (898K shares), BARCLAYS PLC (847K shares), and MORGAN STANLEY (838K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.